NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer.

  • Authors:
    • S D Heys
    • N Langlois
    • I C Smith
    • L G Walker
    • O Eremin
  • View Affiliations

  • Published online on: May 1, 1998     https://doi.org/10.3892/or.5.3.735
  • Pages: 735-744
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

NM23 gene product is a putative metastases suppressor gene which has structural homology to a nucleoside diphosphate kinase. Previous studies examining the relationship between NM23 gene product expression and survival in patients with colorectal cancer have revealed conflicting results. However, no study has focused on young patients with colorectal cancer. This study was carried out to determine if expression of the NM23 gene product was correlated with metastatic potential and survival in young patients (45 years and under) with colorectal cancer. Eighty- one patients with colorectal cancer were studied and the presence of the NM23 gene product (H1) was detected using standard immunohistochemical techniques. NM23 gene product expression did not correlate with tumour stage, lymph node involvement by tumour, presence of distant metastases, extramural vascular invasion or degree of tumour differentiation. Independent risk factors for overall survival were: Dukes' stage (p=0.00001) and extramural vascular invasion (p=0.003). NM23 expression was not an independent prognostic indicator (p=0.55). Therefore, NM23 expression does not correlate with existing indicators of tumour aggressiveness and behaviour nor is it an independent predictor of survival in young patients with colorectal cancer.

Related Articles

Journal Cover

May 1998
Volume 5 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Heys, S., Langlois, N., Smith, I., Walker, L., & Eremin, O. (1998). NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer.. Oncology Reports, 5, 735-744. https://doi.org/10.3892/or.5.3.735
MLA
Heys, S., Langlois, N., Smith, I., Walker, L., Eremin, O."NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer.". Oncology Reports 5.3 (1998): 735-744.
Chicago
Heys, S., Langlois, N., Smith, I., Walker, L., Eremin, O."NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer.". Oncology Reports 5, no. 3 (1998): 735-744. https://doi.org/10.3892/or.5.3.735